 |
 |
Search
- Page Path
-
- HOME
- Search
- IBD
- Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use protect from chronic inflammation-induced atherosclerosis?
- Aikaterini Mantaka, Nikolaos Galanakis, Dimitrios Tsetis, Ioannis E. Koutroubakis
- Intest Res. 2022;20(4):495-505. Published online August 8, 2022
- Full text PubReader ePub PDF
- Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
- Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye, on behalf of the Korean Association for the Study of Intestinal Diseases
- Intest Res. 2023;21(1):137-147. Published online July 12, 2022
- Full text PubReader ePub PDF
|
|
- Infection
- Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
- Karan Sachdeva, Peeyush Kumar, Bhaskar Kante, Sudheer K. Vuyyuru, Srikant Mohta, Mukesh K. Ranjan, Mukesh K. Singh, Mahak Verma, Govind Makharia, Saurabh Kedia, Vineet Ahuja
- Intest Res. 2023;21(2):226-234. Published online June 13, 2022
- Full text PubReader ePub PDF
|
|
- IBD
- Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
- Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye
- Intest Res. 2022;20(2):203-212. Published online April 29, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
- Haruka Otake, Satohiro Matsumoto, Hirosato Mashima
- Intest Res. 2022;20(4):464-474. Published online March 31, 2022
- Full text PubReader ePub PDF
|
|
- Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
- José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset
- Intest Res. 2022;20(3):361-369. Published online March 15, 2022
- Full text PubReader ePub PDF
|
|
- Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
- Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
- Intest Res. 2022;20(4):452-463. Published online March 11, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
- Fares Ayoub, Matthew Odenwald, Dejan Micic, Sushila R. Dalal, Joel Pekow, Russell D. Cohen, David T. Rubin, Atsushi Sakuraba
- Intest Res. 2022;20(2):240-250. Published online February 8, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
- Bhaskar Kante, Pabitra Sahu, Saurabh Kedia, Sudheer K. Vuyyuru, Kapil Soni, Maneesh Singhal, Raju Sharma, Govind Makharia, Vineet Ahuja
- Intest Res. 2022;20(2):231-239. Published online February 8, 2022
- Full text PubReader ePub PDF Supplementary Material
|
|
- Landscape of inflammatory bowel disease in Singapore
- Daren Low, Nidhi Swarup, Toshiyuki Okada, Emiko Mizoguchi
- Intest Res. 2022;20(3):291-296. Published online January 7, 2022
- Full text PubReader ePub PDF
|
|
- Artificial intelligence for endoscopy in inflammatory bowel disease
- Kento Takenaka, Ami Kawamoto, Ryuichi Okamoto, Mamoru Watanabe, Kazuo Ohtsuka
- Intest Res. 2022;20(2):165-170. Published online January 7, 2022
- Full text PubReader ePub PDF
|
|
- Evaluation of nutritional status using bioelectrical impedance analysis in patients with inflammatory bowel disease
- Seung Hyuk Kim, You Sun Kim, Si Hyeong Lee, Hyun Mi Lee, Won Eui Yoon, Seo Hyun Kim, Hee Jun Myung, Jeong Seop Moon
- Intest Res. 2022;20(3):321-328. Published online July 20, 2021
- Full text PubReader ePub PDF
|
|
- Microbiota
- Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn’s disease
- Shigeki Bamba, Osamu Inatomi, Atsushi Nishida, Masashi Ohno, Takayuki Imai, Kenichiro Takahashi, Yuji Naito, Junichi Iwamoto, Akira Honda, Naohiro Inohara, Akira Andoh
- Intest Res. 2022;20(3):370-380. Published online May 14, 2021
- Full text PubReader ePub PDF Supplementary Material
|
|
- Miscellaneous
- Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
- Saurabh Kedia, Raju Sharma, Sudheer Kumar Vuyyuru, Deepak Madhu, Pabitra Sahu, Bhaskar Kante, Prasenjit Das, Ankur Goyal, Karan Madan, Govind Makharia, Vineet Ahuja
- Intest Res. 2022;20(2):184-191. Published online May 4, 2021
- Full text PubReader ePub PDF
|
|
- IBD
- Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
- Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein
- Intest Res. 2022;20(1):72-77. Published online February 3, 2021
- Full text PubReader ePub PDF
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.
